Diabetes Cancer Health Alert: Persons Taking Diabetes Drugs Should Be Aware of a Potential Increased Pancreatic Cancer Health Risk That May Be Caused by Incretin Class Diabetic Drugs by Texas Diabetes Pancreatic Cancer

Diabetes Pancreatic Cancer Health Alert: Persons Taking Diabetes Drugs Should Be Aware of a Potential Increased Pancreatic Cancer Health Risk That May Be Caused by Incretin Class Diabetic Drugs by Texas Diabetes Pancreatic Cancer Lawyer Jason S. Coomer

Recent scientific studies have shown that several diabetes drugs may cause an increased risk of pancreatic cancer.  Persons taking Januvia, Janument, Victoza, Byetta, Onglyza, Tradjenta, Bydureon, Oseni, and other diabetes drugs should be aware of the potential dangers.  If you have been taking a diabetes drug and have been diagnosed with Pancreatic Cancer or you have lost a loved one that was taking a diabetes drug and was diagnosed with pancreatic cancer, please report the adverse action to the prescribing medical doctor and FDA as soon as possible. 

For more information on pancreatic cancer health risks to diabetics, please go to the following web page: Pancreatic Cancer Health Risk Warning: Incretin Class Diabetic Drugs May Cause Increase Risk of Pancreatic Cancer.

Pancreatic Cancer Detection: Understanding and Identifying Symptoms of Pancreatic Cancer Can Be Important In Early Detection and Treatment of Pancreatic Cancer Resulting in Higher Pancreatic Cancer Survival Rates

Symptoms of pancreatic cancer can include: dark urine and clay-colored stools, fatigue and weakness, jaundice (a yellow color in the skin, mucus membranes, or eyes), loss of appetite and weight loss, nausea and vomiting, pain or discomfort in the upper part of the belly or abdomen, back pain, blood clots, diarrhea, and indigestion.  Diabetics who start experiencing these symptoms and are on incretin diabetes drugs should immediately contact their health care provider.

The Most Common Type of Pancreatic Cancer is Pancreatic Adenocarcinoma Which Includes About 90% of Cases of Pancreatic Cancer: Pancreactic Adenocarcinoma is a Form of Exocrine Pancreas Cancer

The most common kind of pancreatic cancer is pancreatic adenocarcinoma and includes about 90% of the cases of pancreatic cancer.  Pancreatic adenocarcinoma is a cancerous overgrowth of exocrine pancreatic cells and is unfortunately commonly undetected until it is too late for the patient.  Pancreatic adenocarcinoma because of late detection can often result a fatal diagnosis with very limited survival time. Other forms of exocrine pancreas cancer include: intraductal papillary mucinous neoplasm (IPMN), adenosquamous carcinomas, acinar cell carcinomas, mucinous cystadenocarcinomas, signet ring cell carcinomas, hepatoid carcinomas, colloid carcinomas, undifferentiated carcinomas, pancreatoblastomas, and undifferentiated carcinomas with osteoclast-like giant cells.